Anne E. White
Executive Vice President and President, Lilly Neuroscience, Eli Lilly and Company
Anne White (she/her/hers) is executive vice president of Eli Lilly and Company and president of Lilly Neuroscience.
Anne has held a range of leadership roles across multiple therapeutic areas, including oncology, neuroscience and infectious disease. She has led the development of multiple late-phase opportunities and has led teams in the submission, approval and launch of several new medicines. She also led Lilly’s successful effort to significantly speed drug development from target identification through launch.
Anne served most recently as senior vice president of Eli Lilly and Company and president of Lilly Oncology, with prior roles in R&D Leadership. She has over 25 years of experience in the pharmaceutical industry. Anne also has experience in small-company pharma, having founded and led a startup company in oncology drug development.
Anne earned a bachelor’s degree in engineering from the University of Michigan.
Anne was awarded the Lilly Women’s Network Award for her efforts in mentoring and supporting women in the workplace. She also serves as the executive sponsor for Lilly’s LGBTQ employee resource group.
